Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Practical Oncology Journal ; (6): 321-328, 2017.
Article in Chinese | WPRIM | ID: wpr-611357

ABSTRACT

Objective This study explored the expression of polyclonal protein SUZ12 in patients with intrahepatic cholangiocarcinoma(ICC),and its role in predicting the survival and treatment of ICC patients.Methods The expression of SUZ12 and p16INK4a was detected by immunohistochemical assay in 207 liver tissue samples including ICC patients,BilIN-1,-2,-3 and non-tumor-like cholangiocarcinoma.The expression of these proteins was assessed to be related to the pathological characteristics of the ICC patients receiving chemotherapy and the outcome of survival as well as the subsequent chemotherapy response.Results The expression level of SUZ12 was gradually increased from non-neoplastic bile duct tissue to BilIN-1,-2,-3 and ICC.The expression of p16INK4a protein was expressed in non-neoplastic-like cholangiocarcinoma,but it decreased gradually in BilIN-1,-2,-3 and ICC tissues.SUZ12 expression was associated with undifferentiated ICC,lymph node metastasis and advanced cancer.Kaplan-Meier curve analysis showed that ICC patients with high expression of SUZ12 had a significant reduction in overall survival and disease-free survival in comparison with ICC patients with the low expression of SUZ12.SUZ12 expression was significantly associated with overall survival of patients receiving adjuvant gemcitabine-based chemotherapy(AGC).Conclusion SUZ12 expression is able to predict the overall survival and disease-free survival of ICC patients with adjuvant gemcitabine-based chemotherapy.

2.
Chinese Journal of General Surgery ; (12): 367-369, 2012.
Article in Chinese | WPRIM | ID: wpr-425704

ABSTRACT

ObjectiveTo explore the efficacy of an antibiotic ertapenem for the treatment of bacterial liver abscess. MethodThe clinical data of 134 hospitalized bacterial liver abscess patients were retrospectively analyzed to evaluate the clinical and bacteriological efficacy of ertapenem from March 2009-2011in our hospital. ResultFever was present in 122 (91%)cases,abdominal pain was complained in 70 (52.2% ) cases and rigor in 66 (49.3% ) cases.In 92(68.7% ) cases the abscess was located in the right lobe of the liver.Leukocytosis and liver dysfunction were found in 73 cases(54.8% ) and 84 cases (62.7% ),respectively.Ultrasonography was the most effective diagnostic means for liver abscess.Fortyone cases(30.6% )were treated conservatively with ertapenem and 82(61.2% )were treated with ertapenem associated with percutaneous liver puncture aspiration and 11cases (8.2% )were treated with ertapenem associated with surgery.The clinical success rate was respectively 89%,87.8%,90.9%.The average duration of medication and length of stay were respectively ( 7.0 ± 2.4 ) d and 14.2 d.Ninety-seven pathogens were isolated from samples and predominant strains were Klebsiella species.Bacterial eradication rate was 92.8%.The sensitivities of isolated bacteria to ertapenem were 94.8%.ConclusionsErtapenem administration is effective therapy for bacterial liver abscess.

SELECTION OF CITATIONS
SEARCH DETAIL